Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1989-06-09
1990-11-13
Bond, Robert T.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
549292, 544374, 546206, 548517, 514255, 514319, 514422, 514459, 514824, A61K 31365, C07D30730
Patent
active
049702319
ABSTRACT:
HMG-CoA reductase inhibitors of formulae (I) and (II) are disclosed. ##STR1##
REFERENCES:
patent: 4448979 (1984-05-01), Terahara et al.
patent: 4537859 (1985-08-01), Terahara et al.
patent: 4604472 (1986-08-01), Ide et al.
patent: 4611068 (1986-09-01), Guindon et al.
patent: 4733003 (1988-03-01), Ide et al.
patent: 4766145 (1988-08-01), Lee et al.
patent: 4855456 (1989-08-01), Lee et al.
patent: 4866090 (1989-09-01), Hoffman et al.
Holtz Wilbur J.
Lee Ta J.
Bond Robert T.
DiPrima Joseph F.
Merck & Co. , Inc.
Russell Mark L.
Winokur Melvin
LandOfFree
4-substituted HMG-CoA reductase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 4-substituted HMG-CoA reductase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4-substituted HMG-CoA reductase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-777194